Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 17 Similar Profiles
Lymphoma, Large B-Cell, Diffuse
Medicine & Life Sciences
Non-Hodgkin's Lymphoma
Medicine & Life Sciences
Lymphoma
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Follicular Lymphoma
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
Hodgkin Disease
Medicine & Life Sciences
B-Cell Lymphoma
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1978 2017
- 2 Finished
Lymphoma Specialized Program of Research Excellence
Macon, W. R., Dogan, A. M., Ansell, S. M., Gupta, M. D., Witzig, T. E., Cerhan, J. R., Habermann, T. M., Ratliff, T. L., Link, B. K., Ratliff, T. L., Juweid, M., Ballas, Z., Link, B. K., Ratliff, T., Geyer, S. M., Weiner, G., Lentz, S., Hohl, R. & Smith, B. J.
9/11/02 → 6/30/17
Project: Research project › Specialized Center
Lymphoma
Non-Hodgkin's Lymphoma
Molecular Epidemiology
B-Lymphocytes
B-Cell Lymphoma
EASTERN COOPERATIVE ONCOLOGY GROUP
Habermann, T. M., Hahn, R. & Edmonson, J.
6/1/78 → 4/30/16
Project: Research project › Cooperative Clinical Research--Cooperative Agreements
Antineoplastic Protocols
Organized Financing
Neoplasms
Research
Clinical Protocols
Research Output 1983 2019
Cause of death in follicular lymphoma in the first decade of the rituximab era: A pooled analysis of French and US cohorts
Sarkozy, C., Maurer, M. J., Link, B. K., Ghesquieres, H., Nicolas, E., Thompson, C. A., Traverse-Glehen, A., Feldman, A. L., Allmer, C., Slager, S. L., Ansell, S. M., Habermann, T. M., Bachy, E., Cerhan, J. R. & Salles, G., Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 144-152 9 p.Research output: Contribution to journal › Article
Follicular Lymphoma
Cause of Death
Lymphoma
Disease-Free Survival
Rituximab
1
Citations
Acute coronary syndromes in patients with active hematologic malignancies – Incidence, management, and outcomes
Park, J. Y., Guo, W., Al-Hijji, M., El Sabbagh, A., Begna, K. H., Habermann, T. M., Witzig, T. E., Lewis, B. R., Lerman, A. & Herrmann, J., Jan 1 2018, (Accepted/In press) In : International Journal of Cardiology.Research output: Contribution to journal › Article
Hematologic Neoplasms
Acute Coronary Syndrome
Incidence
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Troponin
1
Citations
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers
Tolcher, A., Flaherty, K., Shapiro, G. I., Berlin, J., Witzig, T. E., Habermann, T. M., Bullock, A., Rock, E., Elekes, A., Lin, C., Kostic, D., Ohi, N., Rasco, D., Papadopoulos, K. P., Patnaik, A., Smith, L. & Cote, G. M., Jun 1 2018, In : Oncologist. 23, 6, p. 658-e72Research output: Contribution to journal › Article
Oxidative Phosphorylation
Lymphoma, Large B-Cell, Diffuse
Neoplasms
Nausea
Vomiting
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma
Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article
Lymphoma
Pharmaceutical Preparations
Maximum Tolerated Dose
Neutropenia
Hodgkin Disease
A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma
Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.Research output: Contribution to journal › Article
Mantle-Cell Lymphoma
Cyclophosphamide
Dexamethasone
Safety
Peripheral Nervous System Diseases